Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Affymax Inc AFFY

Healthcare Biotechnology
Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with... see more

Recent & Breaking News (GREY:AFFY)

NASDAQ Decliners Watch List AFFY, ZNGA, MEMP

Accesswire March 20, 2013

Free Research Reports on AFFY, LULU, SKUL and TOL Issued by the Bedford Report

Marketwired March 20, 2013

News Buzz: Affymax, Harvest Natural Resources, Starbucks Corporation

Accesswire March 19, 2013

INVESTOR ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Report Affymax Inc. Announces Possible Bankruptcy, Following Class Action Lawsuits Filed. Affymax, Inc. - AFFY

Troy Schwensen March 18, 2013

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess Of $100,000 Investing in Affymax, Inc. to Contact the Firm -- AFFY

Troy Schwensen March 18, 2013

Lifshitz Law Firm Announces Class Action Lawsuits against Affymax, Inc., Impax Laboratories Inc., and Tangoe, Inc.

PR Newswire March 18, 2013

Affymax Announces Reduction in Force to Align Resources Around Ongoing Product Investigation

Business Wire March 18, 2013

Law Offices of Howard G. Smith Announces Investigation On Behalf of Investors of Affymax, Inc.

Business Wire March 13, 2013

New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012

Marketwired March 13, 2013

The Real Story Behind LXP, ICE, DNKN and AFFY

Marketwired March 13, 2013

Lawyers Seek to Restore Investors' Losses and Confidence in Affymax, Announces Deans & Lyons Law Firm LLP

Business Wire March 11, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Affymax, Inc., and Certain Officers - AFFY

Troy Schwensen March 6, 2013

Lawsuit on Behalf of Affymax, Inc. (AFFY) Investors Over Alleged Misleading Statements Announced by Shareholders Foundation

Troy Schwensen March 4, 2013

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Affymax, Inc. To Contact The Firm

PR Newswire March 1, 2013

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Affymax, Inc.

PR Newswire March 1, 2013

Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Affymax, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the April 29, 2013 Lead Plaintiff Deadline -- AFFY

Troy Schwensen March 1, 2013

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Affymax, Inc. (NASDAQ: AFFY)

Marketwired March 1, 2013

INVESTOR ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against Affymax, Inc. - AFFY

Marketwired February 28, 2013

A Securities Fraud Class Action Lawsuit Has Been Filed Against Affymax, Inc., Shareholders Are Encouraged to Contact Holzer Holzer & Fistel, LLC

Business Wire February 28, 2013

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position -- AFFY

Troy Schwensen February 28, 2013